ARTICLE | Company News
CRUK, Astellas partner to discover pancreatic cancer targets
August 9, 2014 12:31 AM UTC
Cancer Research UK (London, U.K.) and its Cancer Research Technology Ltd. commercial arm partnered with Astellas Pharma Inc. (Tokyo:4503) to identify and validate targets to block the autophagy pathwa...